Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
sickle cell disease
Pharma
Pfizer pulls sickle cell disease drug Oxbryta from global markets
The market withdrawal is a blow to Pfizer's $5.4 billion acquisition of Global Blood Therapeutics in 2022.
Angus Liu
Sep 25, 2024 6:00pm
New York hospital creates basketball for sickle cell push
Sep 10, 2024 11:51am
Bluebird down 18% with slow uptake of SCD gene therapy Lyfgenia
Aug 14, 2024 12:07pm
Vertex lifts sales guidance as Casgevy launch picks up
Aug 2, 2024 11:34am
Vertex files suit against US over access to fertility program
Jul 16, 2024 7:36am
'Supacell’ taps Netflix for ‘super’ sickle cell awareness
Jul 15, 2024 10:40am
